Gyre Therapeutics (GYRE) Operating Margin (2010 - 2026)
Gyre Therapeutics (GYRE) operating margin from Jun 30, 2010 to Mar 31, 2026. The current Gyre Therapeutics (GYRE) operating margin is -41.52%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Gyre Therapeutics (GYRE)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 9.86% | -35.50% |
| 2024 | 15.28% | -125.78% |
| 2023 | -59.26% | -758.88% |
| 2022 | 8.99% | -100.75% |
| 2021 | -1197.41% | +337.26% |
| 2020 | -273.84% | -99.92% |
| 2018 | -338200.00% | +15709.53% |
| 2017 | -2139.22% | -20.24% |
| 2014 | -2682.14% | -50.94% |
| 2014 | -5466.67% | +1860.87% |
| 2013 | -278.79% | +19.34% |
| 2013 | -233.62% | +1560.57% |
| 2012 | -14.07% | -98.66% |
| 2012 | -1051.95% | -2587.57% |
| 2012 | 42.29% | +385.78% |
| 2012 | 8.71% | -187.27% |
| 2011 | -9.98% | -79.74% |
| 2011 | -49.23% | +297.33% |
| 2011 | -12.39% | -139.28% |
| 2011 | 31.55% | +106.09% |
| 2010 | 15.31% | -109.51% |
| 2009 | -160.93% | N/A |
Comparison Gyre Therapeutics (GYRE) operating margin with competitors
Gyre Therapeutics (GYRE) operating margin is -41.52%.